Risperidone for dementia-related disturbed behavior in nursing home residents: A clinical experience

International Psychogeriatrics

Volumn 9, Issue 1, 1997, Pages 65-68

  Goldberg, Richard J ^a,b   Goldberg, Jenna ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CARBAMAZEPINE; CARBIDOPA; CHLORPROMAZINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; LEVODOPA; LITHIUM; LOXAPINE SUCCINATE; MOLINDONE; NEUROLEPTIC AGENT; NITRATE; PERPHENAZINE; PHENYTOIN; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; THYROID HORMONE; TIOTIXENE; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

ADULT; AGED; AGITATION; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; DEMENTIA; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NURSING HOME; ORTHOSTATIC HYPOTENSION; QUESTIONNAIRE; SEDATION; SIDE EFFECT; URINE RETENTION;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DEMENTIA; DRUG RESISTANCE; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NURSING ASSESSMENT; NURSING HOMES; QUESTIONNAIRES; RISPERIDONE;

EID: 0030920313     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610297004213     Document Type: Article

References (15)

1. Barnes, R., Veith, R., Okimoto, J., et al. (1982). Efficacy of antipsychotic medications in behaviorally disturbed dementia patients. American Journal of Psychiatry, 139, 1170-1174.
2. Chouinard, G., Jones, B., Remington, G., et al. (1993). A Canadian multicenter placebocontrolled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology, 13, 25-29.
3. Coccaro, E. F., Kramer, E., Zemishlany, Z., et al. (1990). Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. American Journal of Psychiatry, 147, 1640-1645.
4. Factor, S. A., Brown, D., Molho, E. S., & Podskalny, G. D. (1994). Clozapine: A two-year open trial in Parkinson's disease patients with psychosis. Neurology, 44 (Suppl. 3, Pt. 1), 544-546.
5. Hillert, A., Mater, W., Wetzel, H., et al. (1993). Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome - a functional approach. Pharmacopsychiatry, 25, 213-217.
6. Jeanblanc, W., & Davis, Y. B. (1995). Risperidone for treating aggression associated with dementia. American Journal of Psychiatry, 152, 1239.
7. Lee, H., Cooney, J. M., & Lawlor, B. A. (1994). The use of risperidone, an atypical neuroleptic, in Lewy body disease. International Journal of Geriatric Psychiatry, 9, 415-417.
8. Marder, S. R., & Meibach, R. C. (1994). Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825-834.
9. Mesotten, F., Suy, E., Pietquin, M., etal. (1989). Therapeutic effect and safety of risperidone (R64766) in psychotic patients. Psychopharmacology, 99, 445-449.
10. Moriss, R. K., Rovner, B. W., Folstein, M. F., et al. (1990). Delusions in newly admitted residents of nursing homes. American Journal of Psychiatry, 147, 299-302.
11. Petrie, W. M., Ban, T. A., Berney, S., et al. (1982). Loxapine in psychogeriatrics: A placebo-and standard-controlled clinical investigation. Journal of Clinical Psychopharmacology, 2, 122-126.
12. Risse, S. C., & Barnes, R. (1986). Pharmacologic treatment of agitation. Journal of the American Geriatrics Society, 34, 368-376.
13. Rovner, B. W., Kafonek, S., Filipp, L., et al. (1986). Prevalence of mental illness in a community nursing home. American Journal of Psychiatry, 143, 1446-1449.
14. Schneider, L. S., & Sobin, P. B. (1990). Neuroleptic medications in the management of psychogeriatric patients: A double-blind clinical trial. Psychosomatics, 15, 134-138.
15. Tariot, P. N., Podgorski, C. A., & Blazina, L. (1993). Mental disorders in the nursing home: Another perspective. American Journal of Psychiatry, 150, 1063-1069.